3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
22
Lymphoma, Large B-Cell, Diffuse
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Follicular
12
Lymphoma
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Rhabdomyosarcoma
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, B-Cell
6
Leukemia, Biphenotypic, Acute
6
Wilms Tumor
5
Sarcoma, Ewing
5
Recurrence
5
Neuroblastoma
5
Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma, T-Cell
4
Rhabdomyosarcoma, Embryonal
3
Medulloblastoma
3
Lymphoproliferative Disorders
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Down Syndrome
3
Sarcoma
2
Rhabdomyosarcoma, Alveolar
2
Rhabdoid Tumor
2
Plasmablastic Lymphoma
2
Osteosarcoma
2
Interventions
ruxolitinib
9
fludarabine phosphate
8
fludarabine
8
Whole-Body Irradiation
8
Specimen Handling
7
Cytarabine
7
Cyclophosphamide
7
Mycophenolic Acid
6
Tacrolimus
5
Injections
5
Busulfan
5
Biopsy
5
Azacitidine
5
Stem Cell Transplantation
4
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
CPX-351
4
venetoclax
3
luspatercept
3
decitabine and cedazuridine drug combination
3
Liposomes
3
Idarubicin
3
Daunorubicin
3
Cyclosporine
3
Blood Specimen Collection
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
selinexor
2
nilotinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Vincristine
×
90 days
×
Clear all
No trials found.